License AgreementLicense Agreement • July 10th, 2018 • Arcturus Therapeutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 10th, 2018 Company Industry JurisdictionThis LICENSE AGREEMENT (“Agreement”‘) is made as of this 28th day of November, 2012 (“Effective Date”), by and between Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Marina Biotech, Inc., a Delaware corporation (“Marina”). Protiva and Marina are each referred to individually as a “Party” and together as the “Parties.”
License AgreementLicense Agreement • May 14th, 2018 • Arcturus Therapeutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2018 Company Industry JurisdictionThis LICENSE AGREEMENT (“Agreement”‘) is made as of this 28th day of November, 2012 (“Effective Date”), by and between Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Marina Biotech, Inc., a Delaware corporation (“Marina”). Protiva and Marina are each referred to individually as a “Party” and together as the “Parties.”
License Agreement By and Between Protiva Biotherapeutics inc. And Marina Biotech, Inc.License Agreement • October 30th, 2013 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Contract Type FiledOctober 30th, 2013 Company Industry JurisdictionThis LICENSE AGREEMENT (“Agreement”) is made as of this 28th day of November, 2012 (“Effective Date”), by and between Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Marina Biotech, Inc., a Delaware corporation (“Marina”). Protiva and Marina are each referred to individually as a “Party” and together as the “Parties.”
License Agreement By and Between Protiva Biotherapeutics inc. And Marina Biotech, Inc.License Agreement • July 16th, 2013 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Contract Type FiledJuly 16th, 2013 Company Industry JurisdictionThis LICENSE AGREEMENT (“Agreement”) is made as of this 28th day of November, 2012 (“Effective Date”), by and between Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Marina Biotech, Inc., a Delaware corporation (“Marina”). Protiva and Marina are each referred to individually as a “Party” and together as the “Parties.”